 |
 |
 |
| Name |
Symbol |
Market Value (millions) |
Stock Quote |
| 012 Smile.Communications Ltd. |
|
$645.9 |
Stock Quote for SMLC |
| | | Prior to our October 2007 public offering, we were a wholly-owned subsidiary
of Internet Gold, a public company traded on the NASDAQ Global Market and the
Tel Aviv Stock Exchange, whose shares are included in the TASE-100 Index.
Internet Gold currently owns approximately 72.83% of our ordinary shares. In
November 2004, Internet Gold became our sole shareholder after purchasing our
ordinary shares from our prior shareholders. As part of its internal
restructuring in 2006, Internet Gold transferred its communications and media
operations into two operating subsidiaries. Internet Gold transferred to us its
broadband and traditional voice services businesses, which we refer to in this
annual report as the Communications Business. Internet Gold transferred its
media business and we transferred certain media assets, including P1000.co. ... More ... |
|
| 1st Constitution Bancorp (NJ) |
|
$30.9 |
Stock Quote for FCCY |
| | | 1st Constitution Bancorp (the “Company”) is a bank holding company registered
under the Bank Holding Company Act of 1956, as amended. The Company was
organized under the laws of the State of New Jersey in February 1999 for the
purpose of acquiring all of the issued and outstanding stock of 1st Constitution
Bank (the “Bank”) and thereby enabling the Bank to operate within a bank holding
company structure. The Company became an active bank holding company on July 1,
1999. The Bank is a wholly-owned subsidiary of the Company. Other than its
investment in the Bank, the Company currently conducts no other significant
business activities.
The main office of the Company and the Bank is located at 2650 Route 130 North,
Cranbury, New Jersey 08512, and the telephone number is (609) 655-4500.
1st Constitution Bank
The Bank, a commercial bank formed under the laws of the State of New Jersey,
engages in the business of commercial and retail banking. ... More ... |
|
| 1st Pacific Bancorp (CA) |
|
$4.0 |
Stock Quote for FPBN |
| | | 1st Pacific Bancorp (the "Company", "we", "our", or "us") is a California
corporation incorporated on August 4, 2006 and is registered with the Board of
Governors of the Federal Reserve System as a bank holding company under the Bank
Holding Company Act of 1956, as amended. 1st Pacific Bank of California (the
"Bank") is a wholly-owned bank subsidiary of the Company and was incorporated in
California on April 17, 2000. The Bank is a California corporation licensed to
operate as a commercial bank under the California Banking Law by the California
Department of Financial Institutions (the "DFI"). In accordance with the Federal
Deposit Insurance Act, the Federal Deposit Insurance Corporation (the "FDIC")
insures the deposits of the Bank. The Bank is a member of the Federal Reserve
System. ... More ... |
|
| 1st United Bancorp, Inc. (FL) |
|
$196.2 |
Stock Quote for FUBC |
| | | CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
The SEC encourages companies to disclose forward-looking information so that
investors can better understand a company’s future prospects and make informed
investment decisions. This Annual Report on Form 10-K (“Annual Report”) contains
“forward-looking statements” within the meaning of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements include, among
others, statements about our beliefs, plans, objectives, goals, expectations,
estimates and intentions that are subject to significant risks and uncertainties
and are subject to change based on various factors, many of which are beyond our
control. The words “may,” “could,” “should,” “would,” “believe,” “anticipate,”
“estimate,” “expect,” “intend,” “plan,” “target,” “goal,” and similar
expressions are intended to identify forward-looking statements. ... More ... |
|
| 21st Century Holding Company |
|
$32.1 |
Stock Quote for TCHC |
| | | 21st Century Holding Company (“21st Century,” “Company,” “we,” “us”) is an
insurance holding company, which, through our subsidiaries and our contractual
relationships with our independent agents and general agents, controls
substantially all aspects of the insurance underwriting, distribution and claims
process. We are authorized to underwrite homeowners’ property and casualty
insurance, commercial general liability insurance, personal automobile insurance
and commercial automobile insurance in various states with various lines of
authority through our wholly owned subsidiaries, Federated National Insurance
Company (“Federated National”) and American Vehicle Insurance Company (“American
Vehicle”).
The insurable events during 2007 and 2006 did not include any weather related
catastrophic events such as the well publicized series of hurricanes that
occurred in Florida during 2005 and 2004. ... More ... |
|
| 3D Systems Corporation |
|
$271.0 |
Stock Quote for TDSC |
| | | 3D Systems Corporation (“3D Systems” or the “Company”) is a holding company that
operates through subsidiaries in the United States, Europe and the Asia-Pacific
region. We design, develop, manufacture, market and service a suite of additive
manufacturing solutions including 3-D modeling, rapid prototyping and
manufacturing systems and related products and materials that enable complex
three-dimensional objects to be produced directly from computer data.
Our customers use our proprietary systems to produce physical objects from
digital data using commonly available computer-aided design software, often
referred to as CAD software, or other digital-media devices such as engineering
scanners and MRI or CT medical scanners. ... More ... |
|
| A.D.A.M. Inc. |
|
$37.1 |
Stock Quote for ADAM |
| | | A.D.A.M., Inc. (Nasdaq: ADAM) provides high-quality health information services
and benefits technology solutions to healthcare organizations, group insurance
brokers, employers, consumers, and educational institutions. With an
industry-leading employee and human resources (HR) benefits technology system
and one of the largest consumer health information libraries in the world, our
products empower consumers to become better informed about their health and
wellness, manage their personal benefits and health account finances, while
helping organizations reduce the costs of healthcare and benefits
administration. Our products address a large and growing consumer driven
healthcare market.
Consumers use our highly visual and interactive health information and decision
support applications for learning about general health concerns, specific
diseases, medical conditions and treatments, surgical procedures, drug
information, wellness topics, alternative medicine and more. ... More ... |
|
| A123 Systems, Inc. |
|
$1,725.0 |
Stock Quote for AONE |
| | | No business description found. |
|
| ABIOMED, Inc. |
|
$350.1 |
Stock Quote for ABMD |
| | | We are a leading provider of medical devices in circulatory support and offer a
continuum of care in heart recovery to acute heart failure patients. Our
strategy is focused on establishing heart recovery as the goal for all acute
cardiac attacks. Our products are designed to enable the heart to rest, heal and
recover by improving blood flow and/or performing the pumping function of the
heart. We believe we are the only company with commercially available cardiac
assist devices approved for heart recovery by the Food and Drug Administration,
or FDA, and our products have been used to treat thousands of patients to date.
Our products can be used in a broad range of clinical settings, including by
heart surgeons for patients in profound shock and by interventional
cardiologists for patients who are in pre-shock or in need of prophylactic
support in the cardiac catheterization lab, or cath lab. ... More ... |
|
| Acacia Research Corporation |
|
$260.2 |
Stock Quote for ACTG |
| | | Acacia Research Corporation’s operating subsidiaries acquire, develop, license
and enforce patented technologies. Our operating subsidiaries generate license
fee revenues and related cash flows from the granting of licenses for the use of
patented technologies that our operating subsidiaries own or control. Our
operating subsidiaries assist patent owners with the prosecution and development
of their patent portfolios, the protection of their patented inventions from
unauthorized use, the generation of licensing revenue from users of their
patented technologies and, if necessary, with the enforcement against
unauthorized users of their patented technologies. Currently, on a consolidated
basis, our operating subsidiaries own or control the rights to 91 patent
portfolios, which include U.S. patents and certain foreign counterparts,
covering technologies used in a wide variety of industries.
CombiMatrix Group Split-off Transaction and Related Discontinued Operations. ... More ... |
|
| ACADIA Pharmaceuticals Inc. |
|
$49.7 |
Stock Quote for ACAD |
| | | We are a biopharmaceutical company focused on the discovery, development, and
commercialization of small molecule drugs for the treatment of central nervous
system disorders. We currently have six clinical programs and several additional
programs in discovery and development. In our most advanced program, we are
conducting Phase III studies with pimavanserin for the treatment of Parkinson’s
disease psychosis. We have reported positive results from a Phase II trial in
our program with pimavanserin as a co-therapy in schizophrenia. We also have
completed enrollment of a Phase IIb trial in our program with ACP-104 as a
stand-alone treatment for schizophrenia. In addition, we have completed a
proof-of-concept clinical study with pimavanserin for the treatment of sleep
maintenance insomnia in healthy older adults. We have retained worldwide
commercialization rights for our programs with pimavanserin and ACP-104. ... More ... |
|
| Accelrys, Inc. |
|
$165.6 |
Stock Quote for ACCL |
| | | We develop and commercialize scientific business intelligence software for the
aggregation, mining, integration, analysis, simulation, management and
interactive reporting of scientific data used by biologists, chemists, materials
scientists, including nanotechnology researchers, and information technology
professionals for product design and drug discovery and development. Our
technology and services are designed to meet the needs of today’s leading
research and development organizations. We are headquartered in San Diego,
California and were incorporated in Delaware in 1993. Our company website is
located at www.accelrys.com. Copies of our annual reports on Form 10-K,
quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to
those reports are available without charge on our website as soon as reasonably
practicable after being filed with or furnished to the U.S. Securities and
Exchange Commission (the “SEC”). ... More ... |
|
| Access National Corporation |
|
$60.8 |
Stock Quote for ANCX |
| | | Access National Corporation, (the “Corporation”) was organized June 15, 2002
under the laws of Virginia to operate as a bank holding company. The Corporation
has three wholly owned subsidiaries: Access National Bank, Access National
Capital Trust I and Access National Capital Trust II. Effective June 15, 2002,
pursuant to an Agreement and Plan of Reorganization dated April 18, 2002 between
the Corporation and Access National Bank (the “Bank”), the Corporation acquired
all of the outstanding stock of the Bank in a statutory share exchange
transaction. The Corporation does not have any significant operations and serves
primarily as the parent company for the Bank. Access National Capital Trust I
and Access National Capital Trust II were formed for the purpose of issuing
redeemable capital securities. The Corporation’s income is primarily derived
from dividends received from the Bank. These dividends are determined by the
Bank’s earnings and capital position. ... More ... |
|
| Accuray Incorporated |
|
$414.5 |
Stock Quote for ARAY |
| | | We have developed the first and only commercially available intelligent robotic
radiosurgery system, the CyberKnife system, designed to treat solid tumors
anywhere in the body as an alternative to traditional surgery. For over
30 years, traditional radiosurgery systems, or systems that deliver precise,
high dose radiation directly to a tumor, have been used primarily to destroy
brain tumors. Our CyberKnife system represents the next generation of
radiosurgery systems, combining continuous image-guidance technology with a
compact linear accelerator that has the ability to move in three dimensions
according to the treatment plan. Our image-guidance technology continuously
acquires images to track a tumor’s location and transmits any position
corrections to the robotic arm prior to delivery of each dose of radiation. ... More ... |
|
| Achillion Pharmaceuticals, Inc. |
|
$63.2 |
Stock Quote for ACHN |
| | | We are a biopharmaceutical company focused on the discovery, development and
commercialization of innovative treatments for infectious diseases. Within the
anti-infective market, we are currently concentrating on the development of
antivirals for the treatment of HIV infection and chronic hepatitis C and the
development of antibacterials for the treatment of serious hospital-based
bacterial infections. We have advanced our lead drug candidate, elvucitabine for
the treatment of HIV infection, into phase II clinical trials. In addition, we
are advancing two late-stage preclinical candidates: ACH-1095, an NS4A
antagonist for the treatment of chronic hepatitis C, being developed in
collaboration with Gilead Sciences, and ACH-702 for the treatment of serious
hospital-based bacterial infections. We are also developing a series of
inhibitors of HCV protease in early preclinical assessment. ... More ... |
|
| Acorda Therapeutics, Inc. |
|
$1,143.2 |
Stock Quote for ACOR |
| | | We are a commercial-stage biopharmaceutical company dedicated to the
identification, development and commercialization of novel therapies that
improve neurological function in people with multiple sclerosis, or MS, spinal
cord injury, or SCI, and other disorders of the central nervous system, or CNS.
Our marketed product, Zanaflex Capsules, is approved by the U.S. Food and Drug
Administration (FDA) for the management of spasticity. Our lead product
candidate, Fampridine-SR, is in Phase 3 development for the improvement of
walking ability in patients with MS. In September 2006, we reported positive
Phase 3 clinical trial results from our first Phase 3 trial and we expect to
have results from our second Phase 3 trial of Fampridine-SR in the latter part
of the second quarter of 2008. If the results of this trial are favorable, we
intend to submit a New Drug Application (NDA) to the FDA in the first quarter of
2009. ... More ... |
|
| Acorn Energy, Inc. |
|
$77.5 |
Stock Quote for ACFN |
| | | Acorn Energy is a holding company that specializes in acquiring and accelerating
the growth of emerging ventures that promise improvement in the economic and
environmental efficiency of the energy sector. We aim to acquire primarily
controlling positions in companies led by promising entrepreneurs and we add
value by supporting those companies with financing, branding, positioning, and
strategy and business development.
Through our majority-owned operating subsidiaries we provide the following
services:
· RT Solutions. Real time software consulting and development services, provided
through our DSIT subsidiary, with a focus on port security for strategic
energy installations. ... More ... |
|
| Actel Corporation |
|
$288.6 |
Stock Quote for ACTL |
| | | Actel Corporation is the leading supplier of low-power field-programmable gate
arrays (“FPGAs”) and programmable system chips (“PSCs”). Attacking power
consumption from both the chip and the system levels, the Company’s innovative
programmable logic solutions enable power-efficient design. In support of our
nonvolatile Flash- and antifuse-based FPGAs, we offer design and development
software and tools to optimize power consumption; power-smart intellectual
property (“IP”) cores, including industry-standard processor technologies; small
footprint packaging; programming hardware and starter kits; and a variety of
design services. We target a wide range of applications in the aerospace,
automotive, avionics, communications, consumer, industrial, medical, and
military markets that require low power or other attributes of our nonvolatile
Flash and antifuse-based technologies that have an inherent competitive
advantage. ... More ... |
|
| Active Power, Inc. |
|
$65.1 |
Stock Quote for ACPW |
| | | Active Power is a leading designer, manufacturer and distributor of efficient,
reliable and green critical power solutions that provide business continuity and
protect customers in the event of an electrical power disturbance. Our products
are designed to provide power quality to protect customers from voltage
fluctuations such as surges and sags, frequency fluctuations, and to also
provide ride-through, or temporary power to bridge the gap between a power
outage and the restoration of utility power, or the time required to switch to
electrical generator power. Our target customers are those global enterprises
requiring “power insurance” because they have zero tolerance for downtime in
their mission critical operations. The uninterruptible power systems, or UPS, we
manufacture utilize green technology to create a renewable energy source. ... More ... |
|
| ActivIdentity Corporation |
|
$118.2 |
Stock Quote for ACTI |
| | | ActivIdentity was incorporated in the State of Delaware in August 2002 for
the purpose of changing the domicile of the publicly listed company in the
ActivIdentity group of companies, previously ActivCard S.A., from the Republic
of France to the United States.
ActivIdentity Corporation (formerly known as ActivCard Corp.) is a trusted
provider of digital identity assurance solutions for the enterprise, government,
healthcare, and financial services markets worldwide for employer-to-employee,
business-to-consumer and government-to-citizen solutions. We provide software
and hardware products that enable organizations to issue, manage and use trusted
digital identities for secure physical and logical access, secure
communications, and legally binding digital transactions. ... More ... |
|
| Adaptec, Inc. |
|
$369.9 |
Stock Quote for ADPT |
| | | For your convenience, we have included, in Note 21 to the Notes to Consolidated
Financial Statements, a Glossary that contains (1) a brief description of a few
key acronyms commonly used in our industry that are used in this Annual Report
and (2) a list of accounting rules and regulations that are also referred to
herein. These acronyms and accounting rules and regulations are listed in
alphabetical order.
Overview
We provide storage solutions that reliably move, manage and protect critical
data and digital content. We deliver software and hardware components that
provide reliable storage connectivity and advanced data protection to leading
OEMs and through distribution channel partners. Our software and hardware
products range from HBAs, RAID controllers, host RAID software, Adaptec RAID
Code software, Advanced Data Protection software, Storage Management software,
Snapshot software and other solutions that span the SCSI, SAS, SATA and iSCSI
interface technologies. ... More ... |
|
| Addus HomeCare Corporation |
|
$87.2 |
Stock Quote for ADUS |
| | | No business description found. |
|
| ADDvantage Technologies Group, Inc. |
|
$22.3 |
Stock Quote for AEY |
| | | Certain matters discussed in this report constitute forward-looking statements,
within the meaning of the Private Securities Litigation Reform Act of 1995,
including statements which relate to, among other things, expectations of the
business environment in which ADDvantage Technologies Group, Inc. (the
"Company") operates, projections of future performance, perceived opportunities
in the market and statements regarding our goals and objectives and other
similar matters. The words “estimates,” “projects,” “intends,” “expects,”
“anticipates,” “believes,” “plans” and similar expressions are intended to
identify forward-looking statements. These forward-looking statements are found
at various places throughout this report and the documents incorporated into it
by reference. ... More ... |
|
| Adept Technology, Inc. |
|
$27.0 |
Stock Quote for ADEP |
| | | We are a global, leading provider of intelligent robotics systems and services
that provide high performance and economic value throughout the production life
cycle or automated procedure, enabling our customers to achieve precision,
speed, quality and productivity in their assembly, handling, packaging, testing
and other automated processes.
With almost 25 years of operating expertise, Adept has been a pioneer in the
robotics industry. Our robotics solutions are targeted at applications and
processes that require precision, flexibility and high productivity. Through
sales to systems integrators, original equipment manufacturer (“OEM”) partners
and end-user companies, we provide specialized, cost-effective robotics systems
and services to markets including high speed packaged goods, life sciences, disk
drive/electronics and semiconductor; as well as to traditional industrial
markets, including machine tool automation and automotive electronics. ... More ... |
|
| Adolor Corporation |
|
$67.6 |
Stock Quote for ADLR |
| | | Various statements made in this Annual Report on Form 10-K are forward-looking
within the meaning of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements include those which express plan, anticipation,
intent, contingency, goals, targets or future development and/or otherwise are
not statements of historical fact. We have based these forward-looking
statements on our current expectations and projections about future events and
they are subject to risks and uncertainties known and unknown which could cause
actual results and developments to differ materially from those expressed or
implied in such statements. ... More ... |
|
| Aehr Test Systems |
|
$16.9 |
Stock Quote for AEHR |
| | | Aehr Test develops, manufactures and sells systems which are designed to
reduce the cost of testing flash, dynamic random access memory ("DRAM"), and
other memory devices, and to perform reliability screening or burn-in of
complex logic and memory devices. These systems can be used to simultaneously
perform parallel testing and burn-in of packaged integrated circuits ("ICs"),
singulated bare die, or ICs still in wafer form. Leveraging its expertise as a
long-time leading provider of burn-in equipment, with over 2,500 systems
installed worldwide, the Company has developed and introduced several
innovative product families, including the FOXTM, MTX and MAX systems, and the
DiePakR carrier. The FOX system is a full wafer contact parallel test and
burn-in system designed to make contact with all pads of a wafer
simultaneously, thus enabling full wafer parallel test and burn-in. ... More ... |
|
| AEterna Zentaris, Inc. |
|
$51.7 |
Stock Quote for AEZS |
| | | Æterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine
therapy and oncology with expertise in drug discovery, development and
commercialization, primarily targeting the North American and European markets.
We were incorporated on September 12, 1990 under the laws of Canada. Our
registered office is located at 1405
15
--------------------------------------------------------------------------------
du Parc-Technologique Blvd., Quebec City, Quebec, Canada G1P 4P5, our telephone
number is (418) 652-8525 and our website is www.aezsinc.com. None of the
documents or information found on our website shall be deemed to be included in
or incorporated into this annual report.
On December 30, 2002, we acquired Zentaris AG, a biopharmaceutical company based
in Frankfurt, Germany. ... More ... |
|
| Aetrium Incorporated |
|
$30.0 |
Stock Quote for ATRM |
| | | We design, manufacture and market a variety of electromechanical equipment used
in the handling and testing of integrated circuits, or ICs, which constitute the
highest revenue component of the semiconductor industry. Our primary focus is on
high volume ICs and on the latest IC package designs. Our products are purchased
primarily by semiconductor manufacturers and their assembly and test
subcontractors. Our products are used in the test, assembly and packaging, or
TAP, segment of semiconductor manufacturing. Our products automate critical
functions to improve manufacturing yield, raise quality levels, increase product
reliability and reduce manufacturing costs.
We have two principal equipment product lines:
· Test Handler Products. In terms of revenue, this is our largest product
line. ... More ... |
|
| Affymax, Inc. |
|
$387.4 |
Stock Quote for AFFY |
| | | We are a biopharmaceutical company developing novel peptide-based drug
candidates to improve the treatment of serious and often life-threatening
conditions. Our lead product candidate, Hematide™, is designed to treat anemia
associated with chronic renal failure and cancer. Anemia is a serious condition
in which blood is deficient in red blood cells and hemoglobin. It is common in
patients with chronic renal failure, cancer, heart failure, inflammatory
diseases and other critical illnesses, as well as in the elderly. If left
untreated, anemia may lead to chronic fatigue or increase the risk of other
diseases or death. Currently recombinant EPO, or rEPO, is used to manage the
anemia of dialysis, pre-dialysis and cancer patients. According to IMS Health
Incorporated, rEPO generated $13.5 billion in worldwide revenues for the
12 months ended September 2007, of which we believe approximately $9 billion was
generated in the U.S. ... More ... |
|
| AirMedia Group Inc |
|
$512.9 |
Stock Quote for AMCN |
| | | We are a Cayman Islands incorporated holding company that conducts operations
through our subsidiaries, consolidated variable interest entities and the
variable interest entities’ subsidiaries in China. We commenced operations in
August 2005 in China through Shengshi Lianhe, a consolidated variable interest
entity of our principal subsidiary, AM Technology. We established another
wholly-owned subsidiary, Shenzhen AM, in June 2006 in China. In order to
facilitate foreign investment in our company, we established an offshore
28
--------------------------------------------------------------------------------
Table of Contents
holding company, Broad Cosmos Enterprises Limited, or Broad Cosmos, as a company
registered in the British Virgin Islands in June 2006. To prepare for our
initial public offering, we incorporated AirMedia Group Inc. ... More ... |
|
| Akorn, Inc. |
|
$134.7 |
Stock Quote for AKRX |
| | | We manufacture and market diagnostic and therapeutic pharmaceuticals in
specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes,
among others. Our customers include physicians, optometrists, hospitals,
wholesalers, group purchasing organizations and other pharmaceutical companies.
We are a Louisiana corporation founded in 1971 in Abita Springs, Louisiana. In
1997, we relocated our headquarters and certain operations to Illinois. We have
a wholly owned subsidiary named Akorn (New Jersey), Inc., which operates in
Somerset, New Jersey and is involved in manufacturing, product development, and
administrative activities related to our ophthalmic and hospital drugs &
injectables segments.
During the fiscal years ended December 31, 2005 and 2006 and for the nine
months ended September 30, 2007, we had three reporting segments. Our reportable
segments are based upon internal financial reports that disaggregate certain
operating information. ... More ... |
|
| Alexza Pharmaceuticals, Inc. |
|
$137.8 |
Stock Quote for ALXA |
| | | We are an emerging specialty pharmaceutical company focused on the development
and commercialization of novel, proprietary products for the treatment of acute
and intermittent conditions. We currently have six product candidates in
clinical development. Our technology, the Staccato system, vaporizes
excipient-free drugs to form condensation aerosols that, when inhaled, allows
for rapid systemic drug delivery. Because of the particle size of the aerosol,
the drug is quickly absorbed through the deep lung into the bloodstream,
providing speed of therapeutic onset that is comparable to intravenous, or IV,
administration but with greater ease, patient comfort and convenience.
We have identified approximately 200 drug compounds that have demonstrated
initial vaporization feasibility for delivery with our technology. ... More ... |
|
| Alliance Bancorp, Inc. of Pennsylvania |
|
$56.3 |
Stock Quote for ALLB |
| | | Alliance Bancorp, Inc. of Pennsylvania (“Alliance Bancorp” or the “Company”) is
a federally chartered savings and loan holding company which owns 100% of
Alliance Bank (“Bank”) which is a community oriented savings bank headquartered
in Broomall, Pennsylvania. On January 30, 2007, the Bank completed its
reorganization to a mid-tier holding company structure and the sale of the
shares of its common stock. In the reorganization and offering, the Company
sold 1,807,339 shares of common stock at a purchase price of $10.00 per share
and issued 5,417,661 shares of common stock in exchange for former outstanding
shares of Alliance Bank (the “Bank”). Each share of the Bank’s common stock was
converted into 2.09945 shares of the Company’s. The offering resulted in
approximately $16.5 million in net proceeds. The significant asset of the
Company is the capital stock of the Bank. ... More ... |
|
| Allied Healthcare Products, Inc. |
|
$40.1 |
Stock Quote for AHPI |
| | | Allied Healthcare Products, Inc. (“Allied” or the “Company”) manufactures a
variety of respiratory products used in the health care industry in a wide range
of hospital and alternate site settings, including sub-acute care facilities,
home health care and emergency medical care. The Company’s product lines include
respiratory care products, medical gas equipment and emergency medical products.
The Company believes that it maintains significant market shares in selected
product lines.
The Company’s products are marketed under well-recognized and respected brand
names to hospitals, hospital equipment dealers, hospital construction
contractors, home health care dealers, emergency medical products dealers and
others. ... More ... |
|
| Allied Motion Technologies, Inc. |
|
$20.9 |
Stock Quote for AMOT |
| | | Allied Motion Technologies Inc. (Allied Motion or the Company) was organized
under the laws of Colorado in 1962 and operates primarily in the United States
and Europe. Allied Motion utilizes its underlying core "Electromagnetic Motion
Technology/Know How" to provide compact, high performance products as solutions
to a variety of motion applications. The Company is engaged in the business of
designing, manufacturing and selling motor, servo motion and optical encoder
products to a broad spectrum of customers throughout the world. The Company's
products are manufactured at our facilities as well as contract manufacturing
facilities in China and Eastern Europe. ... More ... |
|
| Allos Therapeutics, Inc. |
|
$721.4 |
Stock Quote for ALTH |
| | | We are a biopharmaceutical company focused on developing and commercializing
innovative small molecule drugs for the treatment of cancer. We strive to
develop proprietary products that have the potential to improve the standard of
care in cancer therapy. Our focus is on product opportunities for oncology that
leverage our internal clinical development and regulatory expertise and address
important markets with unmet medical need. We may also seek to grow our existing
portfolio of product candidates through product acquisition and in-licensing
efforts.
Our lead product candidate, PDX (pralatrexate), is a novel antifolate
currently under evaluation in a pivotal Phase 2 trial in patients with relapsed
or refractory peripheral T-cell lymphoma. This trial, which is called PROPEL, is
being conducted under an agreement reached with the U.S. ... More ... |
|
| Allot Communications Ltd. |
|
$90.4 |
Stock Quote for ALLT |
| | | Our principal executive offices are located at 22 Hanagar Street, Neve
Ne’eman Industrial Zone B, Hod-Hasharon 45240, Israel, and our telephone number
is +972 (9) 761-9200. Our website address is www.allot.com. The information on
our website does not constitute part of this annual report. We have irrevocably
appointed Allot Communications, Inc. as our agent to receive service of process
in any action against us in any United States federal or state court. The
address of Allot Communications, Inc. is 7664 Golden Triangle Drive, Eden
Prairie, MN 55344.
We were incorporated in late 1996 as “Ariadne Ltd.” and commenced operations
in 1997. In September 1997, we changed our name to “Allot Communications Ltd.”
Between 1998 and 2000, we focused primarily on developing our technology and
products. In 1998, we shipped our first traffic management product. ... More ... |
|
| Alloy, Inc. |
|
$100.7 |
Stock Quote for ALOY |
| | | We are a media and marketing services company that reaches targeted consumer
segments using a diverse array of assets in interactive, display, direct mail,
content production and educational programming businesses. We operate our
business through three operating segments—Promotion, Media and Placement. The
Promotion segment is comprised of businesses whose products and services are
promotional in nature and includes the Alloy Marketing and Promotions business
and our on-campus marketing and sampling divisions. The Media segment is
comprised of company-owned and represented media assets, including our display
board, Internet, database, specialty print, educational programming and
entertainment businesses. The Placement segment is made up of our businesses
that aggregate and market third party media properties owned by others primarily
in the college, military and multicultural markets. ... More ... |
|
| Alphatec Holdings, Inc. |
|
$231.7 |
Stock Quote for ATEC |
| | | We are a Delaware corporation. We were incorporated in March 2005. Our principal
executive office is located at 2051 Palomar Airport Road, Carlsbad, California
92011. In this Annual Report on Form 10-K, the terms “we,” “us” and “our”
includes Alphatec Holdings, Inc., or Alphatec or Alphatec Holdings, and our
subsidiaries.
We are subject to the informational requirements of the Securities Exchange Act
of 1934, as amended, or the Exchange Act, and, accordingly, file reports, proxy
statements and other information with the Securities and Exchange Commission, or
the SEC. Such reports, proxy statements and other information can be read and
copied at the public reference facilities maintained by the SEC at the Public
Reference Room, 100 F Street, N.E., Room 1580, Washington, D.C. 20549.
Information regarding the operation of the Public Reference Room may be obtained
by calling the SEC at 1-800-SEC-0330. The Securities and Exchange Commission
maintains a website (http://www. ... More ... |
|
| Alto Palermo S.A. |
|
$182.8 |
Stock Quote for APSA |
| | | Our legal name is “Alto Palermo S.A. (APSA)”. We were organized and incorporated
on August 29,1889 under Argentine law as a stock corporation (Sociedad Anónima
or S.A.). Our bylaws were registered in the Superintendence of Corporations
(Inspección General de Justicia or “IGJ”) on February 27, 1976 under number 323,
on page 6, book 85 of the stock corporations volume. Pursuant to our bylaws, our
term of duration expires on August 28, 2087. Our shares are listed and traded on
the Buenos Aires Stock Market (Bolsa de Comercio de Buenos Aires) and our ADS on
the NASDAQ. Our headquarters and principal executive offices are located at
Moreno 877, 22nd Floor, (C1091AAQ), Buenos Aires, Argentina. Our telephone is
+54-(11)-4344-4600. Our Depositary Agent for the ADS in the United States is
Bank of New York whose address is 1258 Church Street Station, New York, New York
10286, and whose telephone is +1-(610)-312-5315. Our website is
www.apsacc.com.ar. ... More ... |
|
| Alvarion Ltd. |
|
$222.1 |
Stock Quote for ALVR |
| | | We were incorporated in September 1992 under the laws of the State of Israel.
Since our inception, we have devoted substantially all of our resources to the
design, development, manufacturing and marketing of wireless products.
On August 1, 2001, Floware merged with and into us. As a result of the merger,
we continued as the surviving company and Floware’s separate existence ceased.
Upon the closing of the merger, we changed our name from BreezeCOM Ltd. to
Alvarion Ltd. On April 1, 2003, we completed an acquisition of most of the
assets and the assumption of related liabilities of InnoWave Wireless Systems
Ltd. In December 2004, we completed the amalgamation of interWAVE Communications
International Ltd., and the interWAVE operations became our Cellular Mobile
business unit (“CMU”). In November 2006, we completed the sale of our CMU to LGC
Wireless, Inc. ... More ... |
|
| AMAG Pharmaceuticals, Inc. |
|
$757.2 |
Stock Quote for AMAG |
| | | Founded in November 1981, Advanced Magnetics, Inc., or the Company, a Delaware corporation, is a biopharmaceutical company engaged in the development and commercialization of therapeutic iron compounds to treat anemia, as well as novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. We have two approved products, Feridex I.V.(R) and GastroMARK(R), and we have two product candidates, ferumoxytol and Combidex(R). Ferumoxytol, the Company’s key product candidate, is being developed for use as an intravenous, or IV, iron replacement therapeutic for the treatment of iron deficiency anemia in chronic kidney disease. Combidex is our investigational functional molecular imaging agent consisting of iron oxide nanoparticles for use in conjunction with magnetic resonance imaging, or MRI, to aid in the differentiation of cancerous from normal lymph nodes. ... More ... |
|
| Ambassadors International, Inc. |
|
$14.7 |
Stock Quote for AMIE |
| | | We are a cruise, marine and travel and events company. Our cruise operations
include U.S.-flagged cruise ships that sail along the inland rivers and coastal
waterways of North America and international-flagged ships that sail to
destinations in the Caribbean, Europe, the Americas and the Greek Isles.
Through our marine business, we are a global provider of marina design and
construction services. Our marine business also offers marine operations,
management and consulting services to marina owners.
Through our travel and events business, we provide event services to
corporations, associations and trade show companies. In addition, we develop,
market, and manage performance improvement programs utilizing travel incentives
and merchandise awards designed to achieve specific corporate objectives,
including achieving sales goals, improving productivity and attracting and
retaining qualified employees. ... More ... |
|
| America First Tax Exempt Investors, L.P. |
|
$125.4 |
Stock Quote for ATAX |
| | | The Partnership was formed on April 2, 1998 under the Delaware Revised Uniform
Limited Partnership Act for the purpose of acquiring, holding, selling and
otherwise dealing with a portfolio of federally tax-exempt mortgage revenue
bonds which have been issued to provide construction and/or permanent financing
of multifamily residential properties. Interest on these bonds is excludable
from gross income for federal income tax purposes. As a result, most of the
income earned by the Partnership is exempt from federal income taxes. Our
general partner is America First Capital Associates Limited Partnership Two
(“AFCA 2”), whose general partner is The Burlington Capital Group LLC
(“Burlington”). Since 1984, Burlington has specialized in the management of
investment funds, many of which were formed to acquire real estate investments
such as tax-exempt mortgage revenue bonds, mortgage securities and multifamily
real estate properties. ... More ... |
|
| American Independence Corp. |
|
$38.3 |
Stock Quote for AMIC |
| | | American Independence Corp. is a Delaware corporation (NASDAQ: AMIC). We are a
holding company principally engaged in health insurance and reinsurance with
principal executive offices located at 485 Madison Avenue, New York, New York
10022.
Our website is located at www.americanindependencecorp.com. Detailed
information about AMIC, its corporate affiliates and insurance products and
services can be found on our website. In addition, we make our Annual Reports
on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and
all amendments to such reports available, free of charge, through our website,
as soon as reasonably practicable after they are filed with or furnished to the
SEC. The information on our website, however, is not incorporated by reference
in, and does not form part of, this Annual Report on Form 10-K.
We provide specialized health coverage and related services to commercial
customers and individuals. ... More ... |
|
| American Pacific Corporation |
|
$48.9 |
Stock Quote for APFC |
| | | We manufacture specialty and fine chemicals, as well as propulsion products sold
to defense, aerospace and pharmaceutical end markets. Our products provide
access to, and movement in, space via solid fuel and propulsion thrusters and
represent the key active ingredient in drug applications such as HIV, epilepsy
and cancer. We also produce specialty chemicals utilized in various applications
such as agricultural and pesticide products and fire extinguishing systems, as
well as manufacture water treatment equipment. Our products are designed to meet
customer specifications and often must meet certain governmental and regulatory
approvals. Our technical and manufacturing expertise and customer service focus
has gained us a reputation for quality, reliability, technical performance and
innovation. Given the mission critical nature of our products, we maintain long
standing strategic customer relationships. ... More ... |
|
| AmeriServ Financial Inc. |
|
$30.3 |
Stock Quote for ASRV |
| | | AmeriServ Financial, Inc. (the Company) is a bank holding company, organized
under the Pennsylvania Business Corporation Law. The Company became a holding
company upon acquiring all of the outstanding shares of AmeriServ Financial Bank
(the Bank) on January 5, 1983. The Company’s other wholly owned subsidiaries
include AmeriServ Trust and Financial Services Company (the Trust Company)
formed in October 1992, and AmeriServ Life Insurance Company (AmeriServ Life)
formed in October 1987.
The Company’s principal activities consist of owning and operating its three
wholly owned subsidiary entities. At December 31, 2007, the Company had, on a
consolidated basis, total assets, deposits, and shareholders’ equity of
$905 million, $710 million and $90 million, respectively. The Company and its
subsidiaries derive substantially all of their income from banking and
bank-related services. ... More ... |
|
| AmeriServ Financial Inc. |
|
$9.6 |
Stock Quote for ASRVP |
| | | AmeriServ Financial, Inc. (the Company) is a bank holding company, organized
under the Pennsylvania Business Corporation Law. The Company became a holding
company upon acquiring all of the outstanding shares of AmeriServ Financial Bank
(the Bank) on January 5, 1983. The Company’s other wholly owned subsidiaries
include AmeriServ Trust and Financial Services Company (the Trust Company)
formed in October 1992, and AmeriServ Life Insurance Company (AmeriServ Life)
formed in October 1987.
The Company’s principal activities consist of owning and operating its three
wholly owned subsidiary entities. At December 31, 2007, the Company had, on a
consolidated basis, total assets, deposits, and shareholders’ equity of
$905 million, $710 million and $90 million, respectively. The Company and its
subsidiaries derive substantially all of their income from banking and
bank-related services. ... More ... |
|
| AMICAS, Inc. |
|
$195.1 |
Stock Quote for AMCS |
| | | AMICAS, Inc. (“we,” “us,” “our,” “AMICAS” or the “Company”), formerly known as
VitalWorks Inc., is a leader in radiology and medical image and information
management solutions. The AMICAS Vision Seriestm products provide a complete,
end-to-end IT solution for imaging centers, ambulatory care facilities,
radiology practices and billing services. Solutions include automation support
for workflow, imaging, revenue cycle management and document management.
Hospital customers are provided a best-of-breed picture archiving and
communication system (“PACS”), featuring advanced enterprise workflow support
and a scalable design that can fully integrate with any hospital information
system (“HIS”), radiology information system (“RIS”), or electronic medical
record (“EMR”). ... More ... |
|
| Amicus Therapeutics, Inc. |
|
$79.0 |
Stock Quote for FOLD |
| | | We are a clinical-stage biopharmaceutical company focused on the discovery,
development and commercialization of a new class of orally-administered, small
molecule drugs, known as pharmacological chaperones, for the treatment of a
range of human genetic diseases. Our lead products in development are Amigal
(migalastat hydrochloride) for Fabry disease, Plicera (isofagomine tartrate) for
Gaucher disease and AT2220 for Pompe disease. We completed our Phase 2 clinical
trials of Amigal, are currently conducting Phase 2 clinical trials of Plicera
and completed Phase 1 clinical trials of AT2220. Fabry, Gaucher and Pompe are
relatively rare disorders but represent substantial commercial markets due to
the severity of the symptoms and the chronic nature of the diseases. The
worldwide net product sales for the five currently approved therapeutics to
treat Fabry, Gaucher and Pompe disease were approximately $1. ... More ... |
|
| Ampal-American Israel Corporation |
|
$163.9 |
Stock Quote for AMPL |
| | | As used in this report on Form 10-K (the “Report”), the term “Ampal” or
“registrant” refers to Ampal-American Israel Corporation. The term “Company”
refers to Ampal and its consolidated subsidiaries. Ampal is a New York
corporation founded in 1942.
The Company primarily acquires interests in businesses located in the
State of Israel or that are Israel-related. Ampal’s investment focus is
principally on companies or ventures where Ampal can exercise significant
influence, on its own or with investment partners, and use its management
experience to enhance those investments. In determining whether to acquire
an interest in a specific company, Ampal considers quality of management,
potential return on investment, growth potential, projected cash flow,
investment size and financing, and reputable investment partners. ... More ... |
|
| Amtech Systems, Inc. |
|
$91.8 |
Stock Quote for ASYS |
| | | Amtech was incorporated in Arizona in October 1981, under the name Quartz
Engineering & Materials, Inc. We changed to our present name in 1987. We conduct
operations through four wholly-owned subsidiaries: Tempress Systems, Inc., a
Texas corporation with all of its operations in The Netherlands, acquired in
1994, also referred to herein as Tempress Systems or Tempress; P.R. Hoffman
Machine Products, Inc., an Arizona corporation based in Carlisle, Pennsylvania,
acquired in July 1997, or PR Hoffman; and Bruce Technologies, Inc., a
Massachusetts corporation based in Billerica, Massachusetts, acquired in July
2004, or Bruce Technologies; and R2D Ingenierie SAS, or R2D, a French
corporation located near Montpellier, France, acquired in October 2007. See
Exhibit 21 Subsidiaries for a complete list of our subsidiaries. ... More ... |
|
| ANADIGICS, Inc. |
|
$224.3 |
Stock Quote for ANAD |
| | | ANADIGICS, Inc. (“we” or the “Company”) is a leading provider of semiconductor
solutions in the rapidly growing broadband wireless and wireline communications
markets. Our products include power amplifiers (PAs), tuner integrated circuits,
active splitters, line amplifiers and other components, which can be sold
individually or packaged as integrated radio frequency (RF) and front end
modules. We believe that we are uniquely positioned to capitalize on the
rapidly-growing voice, data and video segments of the broadband wireless and
wireline communications markets. We offer third generation (3G) products that
use the Wideband Code-Division Multiple Access (W-CDMA) and Enhanced Data Rates
for Global System for Mobile Communication Evolution (EDGE) standards and
combinations of W-CDMA and EDGE platforms (WEDGE), beyond third generation
(3. ... More ... |
|
| Anadys Pharmaceuticals, Inc. |
|
$82.8 |
Stock Quote for ANDS |
| | | Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to
improving patient care by developing novel medicines in the areas of hepatitis C
and oncology. The Company is developing ANA598, a small-molecule, non-nucleoside
inhibitor of the NS5B polymerase for the treatment of hepatitis C and ANA773, an
oral Toll-like receptor 7 (TLR7) agonist prodrug for cancer. Both ANA598 and
ANA773 were discovered at Anadys and are wholly owned assets of Anadys.
We believe that the areas of hepatitis C and oncology are two disease areas
that represent large and significant unmet medical needs. Our objective is to
develop new medicines that will improve the treatment outcomes for patients with
these serious diseases. We believe that meaningful improvements in patient
outcomes offer the highest likelihood for commercial acceptance of our products
if approved for sale.
Our expertise is based on two distinct scientific approaches to treating
disease. ... More ... |
|
| Analysts International Corporation |
|
$11.7 |
Stock Quote for ANLY |
| | | Headquartered in Minneapolis, Minnesota, Analysts International is a diversified
IT services company. In business since 1966, we have sales and customer support
offices in the United States and Canada.
Development of Service Offerings; Business
Analysts International offers our clients a full range of IT consulting
services, including:
· Staffing Services: Serving large, high-volume accounts, our staffing
services provide reasonably priced resources to volume buyers on demand
· Professional Services: Serving mid-market clients in targeted geographic
regions, our professional services are designed to provide professional
resources, such as developers, project managers, business analysts and other
highly-skilled resources that can assist our clients in achieving their
business objectives; and
· Solutions: Providing network services, infrastructure, ... More ... |
|
| Andatee China Marine Fuel Services Corporation |
|
$48.5 |
Stock Quote for AMCF |
| | | Description Not Available |
|
| APAC Customer Services, Inc. |
|
$276.2 |
Stock Quote for APAC |
| | | We are a leading provider of customer care services and solutions to market
leaders in the healthcare, business services, communications, publishing, travel
and entertainment and financial services industries. We operate nine customer
care centers in the United States, two of which are client-owned facilities and
three off-shore customer care centers in the Philippines. As of December 30,
2007, the domestic operations consisted of approximately 4,600 workstations and
the off-shore operations consisted of approximately 3,000 workstations.
Our principal executive office is located at Six Parkway North, Deerfield,
Illinois 60015 and the telephone number at that address is (847) 374-4980. ... More ... |
|
| Applied Energetics, Inc |
|
$32.0 |
Stock Quote for AERG |
| | | Certain statements in this Form 10-K constitute forward-looking statements
within the meaning of the securities laws. Forward-looking statements include
all statements that do not relate solely to the historical or current facts, and
can be identified by the use of forward looking words such as "may", "believe",
"will", "expect", "expected", "project", "anticipate", "anticipated estimates",
"plans", "strategy", "target", "prospects" or "continue". These forward looking
statements are based on the current plans and expectations of our management and
are subject to a number of uncertainties and risks that could significantly
affect our current plans and expectations, as well as future results of
operations and financial condition and may cause our actual results,
performances or achievements to be materially different from any future results,
performances or achievements expressed or implied by such forward-looking
statements. ... More ... |
|
| Arbinet Corporation |
|
$44.9 |
Stock Quote for ARBX |
| | | We are a leading solutions provider for the telecommunications industry, based
primarily upon an electronic market for trading, routing and settling
communications capacity. Members of our exchange, consisting primarily of
communications services providers, anonymously buy and sell voice calls and
Internet capacity through our centralized, efficient and liquid marketplace.
Communications services providers that do not use our exchange generally
individually negotiate and buy access to the networks of other communications
services providers to send voice calls and Internet capacity outside of their
networks. We believe that we provide a cost-effective and efficient alternative
to these direct connections. With a single interconnection to our exchange,
members have access to all other members’ networks. Members place orders through
our easy-to-use web-based interface. ... More ... |
|
| Arc Sight, Inc. |
|
$817.4 |
Stock Quote for ARST |
| | | We are a leading provider of compliance and security management solutions that
protect enterprises and government agencies. Our products help customers comply
with corporate and regulatory policy, safeguard their assets and processes and
control risk. Our platform collects and correlates user activity and event data
across the enterprise so that businesses can rapidly identify, prioritize and
respond to compliance violations, policy breaches, cybersecurity attacks and
insider threats.
Our security information and event management, or SIEM, platform delivers a
centralized, real-time view of disparate digital alarms, alerts and status and
activity messages, which we refer to as events, across geographically dispersed
and heterogeneous business and technology infrastructures. ... More ... |
|
| Arca Biopharma, Inc. |
|
$21.8 |
Stock Quote for ABIO |
| | | We have included or incorporated by reference into this Annual Report on Form
10-K statements that may constitute “forward-looking statements” as that term is
defined in the Private Securities Litigation Reform Act of 1995. Forward-looking
statements may be identified by words including “anticipate,” “believe,”
“intends,” “estimates,” “expect,” “should,” “may,” “potential” and similar
expressions. Such statements are based on our management’s current expectations
and involve risks and uncertainties. Our actual results and performance could
differ materially from those projected in the forward-looking statements as a
result of many factors discussed in this Annual Report, including those set
forth in this section under the caption “Item 1A. Risk Factors,” as well as
those under “Item 7. Management’s Discussion and Analysis of Financial Condition
and Results of Operations,” and those discussed elsewhere in this Annual Report
on Form 10-K. ... More ... |
|
| Archipelago Learning, Inc. |
|
$447.2 |
Stock Quote for ARCL |
| | | Description Not Available |
|
| Ardea Biosciences, Inc. |
|
$268.1 |
Stock Quote for RDEA |
| | | Ardea Biosciences, Inc., headquartered in San Diego, California, is a
biotechnology company focused on the discovery and development of small-molecule
therapeutics for the treatment of HIV, cancer and inflammatory diseases,
including gout. We believe that we are well-positioned to create shareholder
value through our development activities given our ability to achieve clinical
proof-of-concept relatively quickly and cost-effectively in these disease areas.
We are currently pursuing multiple development programs, including the
following:
Product Portfolio
Product candidate Target Indication Development Status
RDEA806 HIV Phase 2a
2nd generation NNRTI HIV Entering Phase 0
RDEA806 Gout Entering Phas ... More ... |
|
| Arden Group, Inc. |
|
$298.1 |
Stock Quote for ARDNA |
| | | The Registrant, Arden Group, Inc. (Company or Arden), is a holding company which
conducts operations through its wholly-owned subsidiary, Arden-Mayfair, Inc.
(Arden-Mayfair) and Arden-Mayfair’s wholly-owned subsidiary, Gelson’s Markets
(Gelson’s) which operates supermarkets in Southern California. The Company also
owns certain real estate properties through a subsidiary, Mayfair Realty, Inc.
(Mayfair Realty) which is wholly-owned by the Company and Arden-Mayfair.
Arden is headquartered at 2020 South Central Avenue, Compton, California 90220
and its telephone number is (310) 638-2842.
Market Operations
As of December 29, 2007, Gelson’s operated 18 full-service supermarkets in
Southern California, which carry both perishable and grocery products, 17 under
the name “Gelson’s” and one under the name “Mayfair. ... More ... |
|
| Arena Pharmaceuticals, Inc. |
|
$295.8 |
Stock Quote for ARNA |
| | | We are a clinical-stage biopharmaceutical company focused on discovering,
developing and commercializing oral drugs in four major therapeutic areas:
cardiovascular, central nervous system, inflammatory and metabolic diseases. Our
most advanced drug candidate, lorcaserin hydrochloride, or lorcaserin, is being
investigated in a Phase 3 clinical trial program for the treatment of obesity.
We have a broad pipeline of novel compounds that selectively target known and
orphan G protein-coupled receptors, or GPCRs, and includes compounds being
developed by our partners, Ortho-McNeil Pharmaceutical, Inc., a Johnson &
Johnson company, or Ortho-McNeil, and Merck & Co., Inc., or Merck.
We focus on GPCRs because they are a validated class of drug targets that
mediate the majority of cell-to-cell communication in humans. ... More ... |
|
| ARIAD Pharmaceuticals, Inc. |
|
$256.1 |
Stock Quote for ARIA |
| | | The following Business Section contains forward-looking statements, which
involve risks and uncertainties. Our actual results could differ materially from
those anticipated in these forward-looking statements as a result of certain
factors (see Part I, Item 1A: Risk Factors). Unless the content requires
otherwise, references to “ARIAD,” “we,” “our,” and “us,” in this Annual Report
on Form 10-K refer to ARIAD Pharmaceuticals, Inc. and our subsidiaries.
Overview
Our Business and Strategy
We are engaged in the discovery and development of breakthrough medicines to
treat cancers by regulating cell signaling with small molecules. We are
developing a comprehensive approach to patients with cancer that addresses the
greatest medical need — aggressive and advanced-stage cancers for which current
treatments are inadequate. ... More ... |
|
| Ark Restaurants Corp. |
|
$47.1 |
Stock Quote for ARKR |
| | | We are a New York corporation formed in 1983. As of the fiscal year ended
September 29, 2007, we owned and/or operated 23 restaurants and bars, 24 fast
food concepts, catering operations, and wholesale and retail bakeries through
our subsidiaries. Initially our facilities were located only in New York City.
As of the fiscal year ended September 29, 2007, seven of our restaurant and bar
facilities are located in New York City, four are located in Washington, D.C.,
five are located in Las Vegas, Nevada, two are located in Atlantic City, New
Jersey, three are located at the Foxwoods Resort Casino in Ledyard, Connecticut
and one is located in the Faneuil Hall Marketplace in Boston, Massachusetts.
In 2004, we established operations in Florida which include five fast food
facilities in Tampa, Florida and seven fast food facilities in Hollywood,
Florida, each at a Hard Rock Hotel and Casino operated by the Seminole Indian
Tribe at these locations. ... More ... |
|
| Arotech Corporation |
|
$26.8 |
Stock Quote for ARTX |
| | | We are a defense and security products and services company, engaged in three
business areas: high-level armoring for military and nonmilitary air and ground
vehicles; interactive simulation for military, law enforcement and commercial
markets; and batteries and charging systems for the military. We operate
primarily through our various subsidiaries, which we have organized into three
divisions. Our divisions and subsidiaries (all 100% owned by us) are as follows:
† We develop, manufacture and market advanced high-tech multimedia and
interactive digital solutions for use-of-force training and driving training
of military, law enforcement, security and other personnel through our
Training and Simulation Division:
· We provide simulators, systems engineering and software products to the United
States military, government and private industry through our subsidiary FAAC
Incorpo ... More ... |
|
| ArQule, Inc. |
|
$138.1 |
Stock Quote for ARQL |
| | | We are a clinical-stage biotechnology company organized as a Delaware
corporation in 1993 and engaged in the research and development of innovative
cancer therapeutics. Our mission is to introduce novel products that act
selectively against cancer cells, target multiple tumor types and are well
tolerated by patients. We believe our clinical stage products represent
potential best-in-class or first-in-class small molecule candidates based on
highly differentiated mechanisms of action.
Our lead products, which are in clinical-stage testing, consist of: ARQ 197,
an orally administered inhibitor of the c-Met receptor tyrosine kinase; ARQ 501,
an intravenously administered novel activator of the cell's DNA damage response
mechanism mediated by the E2F-1 transcription factor; and ARQ 171, an
intravenously administered second generation activator of E2F-1. ... More ... |
|
| Array BioPharma Inc. |
|
$118.3 |
Stock Quote for ARRY |
| | | Array BioPharma Inc. is a biopharmaceutical company focused on the discovery,
development and commercialization of targeted small molecule drugs to treat
cancer and inflammatory diseases. Our proprietary drug development pipeline
includes clinical candidates that are designed to regulate therapeutically
important target proteins and are aimed at large market opportunities. We
currently have 10 programs in our development pipeline, eight of which are
wholly owned by us.
Our eight most advanced development programs that we wholly own and control
consist of ARRY-543, an ErbB-2/EFGR dual inhibitor for cancer; ARRY-162, a MEK
inhibitor for inflammation; ARRY-797, a p38 inhibitor for inflammation and for
cancer; ARRY-520, a KSP inhibitor for cancer; ARRY-380, an ErbB-2 inhibitor for
cancer; and ARRY-614, a p38/Tie 2 dual inhibitor for inflammation and for
cancer. ... More ... |
|
| Art Technology Group, Inc. |
|
$486.2 |
Stock Quote for ARTG |
| | | We develop and market a comprehensive suite of e-commerce software products and
software-as-a-service (“SaaS”) solutions as well as provide related services,
including support and maintenance, professional services, application hosting,
eStara e-commerce optimization services solutions for enhancing online sales,
and education. Our customers use our products and services to power their
e-commerce websites, attract prospects, convert sales, and offer ongoing
customer care services. Our solutions are designed to provide a scalable,
reliable and sophisticated e-commerce website for our customers to create a
satisfied, loyal and profitable online customer base.
Corporate Information
We were incorporated in 1991 in the Commonwealth of Massachusetts and in 1997 in
the State of Delaware, and have been a publicly traded corporation since 1999.
Our corporate headquarters are at One Main Street, Cambridge, Massachusetts
02142. ... More ... |
|
| ArthroCare Corporation |
|
$691.9 |
Stock Quote for ARTC |
| | | Description Not Available |
|
| Aruba Networks, Inc. |
|
$923.1 |
Stock Quote for ARUN |
| | | We securely deliver the enterprise network to users, wherever they work or roam,
by providing user-centric networks that expand the reach of traditional
port-centric networks. User-centric networks integrate adaptive wireless local
area networks (WLANs), application continuity services, and identity-based
security into a cohesive, high-performance system that can be deployed as an
overlay to existing enterprise networks. Adaptive WLANs deliver
high-performance, follow-me connectivity so users are always connected.
Application continuity services enable follow-me applications that can be
seamlessly accessed across WLAN and cellular networks. Identity-based security
associates access policies with users, not ports, to enable follow-me security
that is enforced regardless of access method or location. ... More ... |
|
| ARYx Therapeutics, Inc. |
|
$81.4 |
Stock Quote for ARYX |
| | | ARYx Therapeutics, Inc., or ARYx, is a biopharmaceutical company focused on
developing a portfolio of internally discovered product candidates designed to
eliminate known safety issues associated with well-established, commercially
successful drugs. We were incorporated in the State of California on
February 28, 1997 and reincorporated in the State of Delaware on August 29,
2007. We maintain a wholly-owned subsidiary, ARYx Therapeutics Limited, with
registered offices in the United Kingdom, which has had no operations since its
inception in September 2004.
We use our RetroMetabolic Drug Design technology to design structurally
unique molecules that retain the efficacy of these original drugs but are
metabolized through a potentially safer pathway to avoid specific adverse side
effects associated with these compounds. ... More ... |
|
| Ascent Media Corporation |
|
$332.2 |
Stock Quote for ASCMA |
| | | No business description found. |
|
| Ascent Solar Technologies, Inc. |
|
$112.1 |
Stock Quote for ASTI |
| | | We are a development stage company formed in October 2005 to commercialize
flexible photovoltaic (PV) modules using proprietary technology. Our technology
was initially developed at ITN Energy Systems, Inc. (ITN) by our founder and
core scientific team beginning in 1994 and subsequently assigned and licensed to
us. Our proprietary manufacturing process deposits multiple layers of materials,
including a thin film of highly efficient copper-indium-gallium-diselenide
(CIGS) semiconductor material, on a flexible, lightweight, plastic substrate and
then laser patterns the layers to create interconnected PV cells, or PV modules,
in a process known as monolithic integration. ... More ... |
|
| Ascent Solar Technologies, Inc. |
|
$10.8 |
Stock Quote for ASTIZ |
| | | We are a development stage company formed in October 2005 to commercialize
flexible photovoltaic (PV) modules using proprietary technology. Our technology
was initially developed at ITN Energy Systems, Inc. (ITN) by our founder and
core scientific team beginning in 1994 and subsequently assigned and licensed to
us. Our proprietary manufacturing process deposits multiple layers of materials,
including a thin film of highly efficient copper-indium-gallium-diselenide
(CIGS) semiconductor material, on a flexible, lightweight, plastic substrate and
then laser patterns the layers to create interconnected PV cells, or PV modules,
in a process known as monolithic integration. ... More ... |
|
| Astro-Med, Inc. |
|
$54.1 |
Stock Quote for ALOT |
| | | Astro-Med, Inc. (the Company) designs, develops, manufactures and distributes a
broad range of specialty printers and electronic instruments which incorporate
advance technologies including both hardware and software. Target markets for
products of the Company include aerospace, automotive, avionics, transportation,
communications, computer peripherals, apparel, food and beverage, chemicals,
distribution, life sciences, packaging and general manufacturing.
The Company’s products are distributed through its own domestic and
international sales force in North America and Western Europe and by authorized
dealers elsewhere in the world. Approximately 30% of the Company’s sales in
fiscal 2008 were to customers located outside the United States. ... More ... |
|
| Astronics Corporation |
|
$65.7 |
Stock Quote for ATRO |
| | | Astronics is a leading supplier of advanced, high-performance lighting,
electronics and power distribution systems for the global aerospace industry. We
sell our products to airframe manufacturers (OEM’s) in the commercial transport,
business jet, military markets, OEM suppliers, and aircraft operators around the
world. The Company provides its products through its wholly owned subsidiaries
Luminescent Systems, Inc., Luminescent Systems Canada, Inc., and Astronics
Advanced Electronic Systems Corp. (AES).
Strategy
Astronics’ strategy for growth is to continue to develop or acquire the
necessary technology to evolve into a leading aircraft lighting, electronics and
power generation and distribution systems integrator, increasing the value and
content we provide on a growing base of aircraft and missile platforms. ... More ... |
|
| ATA Inc. |
|
$83.4 |
Stock Quote for ATAI |
| | | Our predecessor company, American Testing Authority, Inc., a New York
company, began operations in 1999, and in that same year established ATA Testing
Authority (Beijing) Limited, or ATA Testing, as a wholly owned subsidiary in
China. In November 2001 our founders established ATA Testing Authority
(Holdings) Limited, or ATA BVI, in the British Virgin Islands. The following
year American Testing Authority, Inc. merged into ATA BVI and ATA BVI became our
holding company.
In June 2003, we established a Chinese joint venture company, ATA Learning
(Beijing) Inc., or ATA Learning, with Yinchuan Holding. Initially, we held a 40%
equity interest in ATA Learning. ... More ... |
|
| Atlantic American Corporation |
|
$31.2 |
Stock Quote for AAME |
| | | Atlantic American Corporation, a Georgia corporation incorporated in 1968 (the
“Parent” or “Company”), is a holding company that operates through its
subsidiaries in well-defined specialty markets within the life and health and
property and casualty insurance industries. Atlantic American’s principal
operating subsidiaries are American Southern Insurance Company and American
Safety Insurance Company (collectively known as “American Southern”) and Bankers
Fidelity Life Insurance Company (“Bankers Fidelity”). Each subsidiary is managed
separately based upon the geographic location or the type of products offered
and is evaluated on its individual performance. The Company’s strategy is to
focus on well-defined geographic, demographic and/or product niches within the
insurance market place. Each of the Company’s subsidiaries operates with
relative autonomy, which is designed to allow for quick reaction to market
opportunities. ... More ... |
|
| Atlantic Coast Federal Corporation |
|
$19.4 |
Stock Quote for ACFC |
| | | This Form 10-K/A contains forward-looking statements which are statements that
are not historical or current facts. When used in this filing and in future
filings by Atlantic Coast Federal Corporation with the Securities and Exchange
Commission, in Atlantic Coast Federal Corporation’s press releases or other
public or shareholder communications, or in oral statements made with the
approval of an authorized executive officer, the words or phrases, “anticipate,”
“would be,” “will allow,” “intends to,” “will likely result,” “are expected to,”
will continue,” “is anticipated,” “estimated,” “projected,” or similar
expressions are intended to identify, “forward looking statements. ... More ... |
|
| Atlantic Southern Financial Group, Inc. |
|
$14.2 |
Stock Quote for ASFN |
| | | Unless otherwise indicated, all references to “Atlantic Southern,” “we,” “us,”
and “our” in this Annual Report on Form 10-K refer to Atlantic Southern
Financial Group, Inc. and our wholly-owned subsidiary, Atlantic Southern Bank.
BUSINESS
Atlantic Southern Financial Group, Inc.
We are a bank holding company headquartered in Macon, Georgia and, through our
wholly-owned subsidiary, Atlantic Southern Bank, we operate nine banking
locations in the central Georgia markets of Macon, Warner Robins, Roberta,
Lizella, Bonaire and Byron, six in the coastal Georgia markets of Savannah,
Darien, Rincon, Brunswick and St. Simons Island, Georgia, a loan production
office in the South Georgia market of Valdosta, Georgia and one banking location
in Jacksonville, Florida. We serve the banking and financial needs of various
communities in central and coastal Georgia. ... More ... |
|
| AtriCure, Inc. |
|
$87.1 |
Stock Quote for ATRC |
| | | We are a medical device company and a leader in developing, manufacturing and
selling innovative cardiac surgical ablation systems designed to create precise
lesions, or scars, in cardiac, or heart, tissue. Medical journals have described
the adoption by leading cardiothoracic surgeons of our Isolator ® bipolar
ablation clamp system as a treatment alternative during open-heart surgical
procedures to create lesions in cardiac tissue to block the abnormal electrical
impulses that cause atrial fibrillation, or AF, a rapid, irregular quivering of
the upper chambers of the heart. Additionally, leading cardiothoracic surgeons,
treatment guidelines as published by the Heart Rhythm Society and publications
in medical journals have described our Isolator ® system as a standard treatment
alternative for AF patients who may be candidates for sole-therapy minimally
invasive surgical procedures. ... More ... |
|
| Atrinsic, Inc. |
|
$16.3 |
Stock Quote for ATRN |
| | | With respect to this discussion, the terms “we,” “us,” “our,” “New Motion”, and
the “Company” refer to New Motion, Inc., a Delaware corporation and its
wholly-owned subsidiaries, including New Motion Mobile, Inc. and Traffix, Inc.
(“Traffix”), also Delaware corporations.
A Note Concerning Presentation
This Annual Report on Form 10-KSB contains information concerning New Motion,
Inc. as it pertains to the period covered by this report – for the two years
ended December 31, 2007. As a result of the acquisition of Traffix, Inc., a
Delaware corporation (“Traffix”), by New Motion, Inc. on February 4, 2008
(explained herein), this Annual Report on Form 10-KSB also contains information
concerning the combination of New Motion and Traffix, as of the date of this
Annual Report. ... More ... |
|
| ATS Medical, Inc. |
|
$182.8 |
Stock Quote for ATSI |
| | | ATS Medical, Inc. (hereinafter the “Company,” “ATS,” “we,” “us,” or “our”) is a
Minnesota corporation established in 1987. Our common shares are traded on the
NASDAQ Global Market under the symbol ATSI.
We develop, manufacture, and market medical devices for the treatment of
structural heart disease. Our product offerings are focused on heart valve
therapy and the surgical treatment of cardiac arrhythmias. Our core mission is
to build a company with a diversified product portfolio focused exclusively on
the cardiac surgeon. Our objectives are to establish ATS products as the
standard of care for patients with structural heart disease.
From our founding until 2004, 100% of our revenue was from our first product – a
mechanical heart valve. Sales of our mechanical heart valves represented
approximately 72% of our revenue in 2007, compared to 82% and 90% of revenue in
2006 and 2005, respectively. ... More ... |
|
| Auburn National Bancorporation, Inc. |
|
$66.7 |
Stock Quote for AUBN |
| | | Auburn National Bancorporation, Inc. (the “Company”) is a bank holding company
registered with the Board of Governors of the Federal Reserve System (the
“Federal Reserve”) under the Bank Holding Company Act of 1956, as amended (the
“BHC Act”). The Company was incorporated in Delaware in 1990, and in 1994 it
succeeded its Alabama predecessor as the bank holding company controlling
AuburnBank, an Alabama state member bank with its principal office in Auburn,
Alabama (the “Bank”). The Company and its predecessor have controlled the Bank
since 1984. As a bank holding company, the Company may diversify into a broader
range of financial services and other business activities than currently are
permitted to the Bank under applicable law. The holding company structure also
provides greater financial and operating flexibility than is presently permitted
to the Bank. ... More ... |
|
| Audiovox Corporation |
|
$136.1 |
Stock Quote for VOXX |
| | | Audiovox Corporation (“Audiovox", “We", "Our", "Us" or “Company") is a leading
international distributor and value added service provider in the accessory,
mobile and consumer electronics industries. We conduct our business through
seven wholly-owned subsidiaries: American Radio Corp., Audiovox Accessories
Corp. (“AAC”), Audiovox Consumer Electronics, Inc., Audiovox Electronics
Corporation ("AEC"), Audiovox German Holdings GmbH ("Audiovox Germany"),
Audiovox Venezuela, C.A. and Code Systems, Inc. ("Code"). We market our products
under the Audiovox® brand name and other brand names, such as Acoustic
Research®, Advent®, Ambico®, Car Link®, Chapman®, Code-Alarm®, Discwasher®,
Energizer®, Heco®, Incaar®, Jensen®, Mac Audio®, Magnat®, Movies2Go®, Oehlbach®,
Phase Linear®, Prestige®, Pursuit®, RCA® (effective January 1, 2008), RCA
Accessories®, Recoton®, Road Gear®, Spikemaster® and Terk®, as well as private
labels through a large domestic and international distribution network. ... More ... |
|
| AuthenTec, Inc. |
|
$64.8 |
Stock Quote for AUTH |
| | | We are a leading mixed-signal semiconductor company providing fingerprint
authentication sensors and solutions to the high-volume PC, wireless device,
access control and other markets. The fingerprint sensor market is experiencing
rapid growth driven by the proliferation of mobile computing and wireless
communication devices. These devices store an increasing amount of sensitive and
valuable personal and corporate data, yet are highly vulnerable to loss, theft,
intrusion and fraud. In light of these vulnerabilities, the enhanced security
features provided by our solutions have become increasingly important. We
believe our products, which are based on our patented TruePrint technology, are
the most accurate, reliable, cost-effective, easy to use and versatile products
commercially available today. ... More ... |
|
| Autobytel Inc. |
|
$49.7 |
Stock Quote for ABTL |
| | | The Securities and Exchange Commission (“SEC”) encourages companies to disclose
forward-looking information so that investors can better understand a company’s
future prospects and make informed investment decisions. This Annual Report and
our proxy statement, parts of which are incorporated herein by reference,
contain such forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Words such as “anticipate,”
“estimate,” “expects,” “projects,” “intends,” “plans,” “believes” and words of
similar substance used in connection with any discussion of future operations or
financial performance identify forward-looking statements. In particular,
statements regarding expectations and opportunities, new product expectations
and capabilities, and our outlook regarding our performance and growth are
forward-looking statements. This Annual Report also contains statements
regarding plans, goals and objectives. ... More ... |
|
| Avanir Pharmaceuticals, Inc |
|
$143.9 |
Stock Quote for AVNR |
| | | This Annual Report on Form 10-K contains forward-looking statements concerning
future events and performance of our Company. When used in this report, the
words “intend,” “estimate,” “anticipate,” “believe,” “plan,” “goal” and “expect”
and similar expressions as they relate to Avanir are included to identify
forward-looking statements. These forward-looking statements are based on our
current expectations and assumptions and many factors could cause our actual
results to differ materially from those indicated in these forward-looking
statements. You should review carefully the factors identified in this report
under the caption “Risk Factors.” We disclaim any intent to update or announce
revisions to any forward-looking statements to reflect actual events or
developments. Except as otherwise indicted herein, all dates referred to in this
Report represent periods or dates fixed with reference to the calendar year,
rather than our fiscal year ending September 30. ... More ... |
|
| AVI BioPharma, Inc. |
|
$160.1 |
Stock Quote for AVII |
| | | AVI BioPharma, Inc. is a biopharmaceutical company developing therapeutic
products principally based on third-generation NeuGene antisense technology (in
this report, “we,” “our,” “us,” “AVI,” and “Company” refers to AVI
BioPharma, Inc.). Our principal products in development target life-threatening
diseases, including cardiovascular, infectious, and genetic diseases. Currently
approved drugs or other therapies for these diseases often prove to be
ineffective or produce undesirable side effects. Our pre-clinical and clinical
studies indicate that our technology may lead to development of drugs that we
believe offer more effective treatment options with fewer side effects than
currently approved products. A patent estate including 186 patents (foreign and
domestic) issued or licensed to us and 192 pending patent applications (domestic
and foreign) protects our technologies. ... More ... |
|
| Aviat Networks, Inc. |
|
$348.8 |
Stock Quote for AVNW |
| | | Description Not Available |
|
| Aware, Inc. |
|
$47.7 |
Stock Quote for AWRE |
| | | We have been a leading innovator in Digital Subscriber Line (“DSL”) technology
for over a decade. This technology is specified at industry standards bodies and
is used by telephone companies worldwide to deliver high speed data over their
copper telephone networks. Our DSL technology focus is on asymmetric DSL
(“ADSL”) and very high speed DSL (“VDSL”). The newest standards, known as ADSL2+
and VDSL2 enable data rates high enough for phone companies to deploy
entertainment-quality services such as television, including Internet Protocol
television (“IPTV”) and video-on-demand, and support high-definition formats
such as HDTV.
IPTV provides phone companies a means to deliver a superior and differentiated
TV service by offering more channel selections, better quality and an improved
user experience with multiple viewing panes and instantaneous channel
switching. IPTV is expected to drive increased demand for the fastest versions
of DSL service over the next several years. ... More ... |
|
| AXT Inc |
|
$88.9 |
Stock Quote for AXTI |
| | | AXT, Inc. ("AXT", "we," "us," and "our" refer to AXT, Inc. and all of its
subsidiaries) is a leading developer and producer of high-performance compound
and single element semiconductor substrates, including substrates made from
gallium arsenide (GaAs), indium phosphide (InP) and germanium (Ge). We currently
sell the following substrate products in the sizes and for the applications
indicated:
Substrate
Substrates Diameter Applications
---------------------- ------------------ -----------------------------------------
GaAs (semi-insulating) 2", 3", 4", 5", 6" • Power amplifiers and radio frequency
integrated circuits for wireless
handsets (cell phones)
• Direct broadcast television ... More ... |
|
|
